Tongrentangcare 02667 Prospectus Information

IPO Timeline Raw facts

Broker Deadline

2026-07-02

Morning deadline

HKEX Deadline

2026-07-02

Noon deadline

Broker Results (T-2)

2026-07-03

Some brokers release in afternoon

Grey Market (T-1)

2026-07-06

Afternoon

HKEX Allotment (T-1)

2026-07-06

Evening

Registrar Allotment (T-1)

2026-07-06

Evening

Listing Day (T)

2026-07-07

First day of trading

Company Overview

Stock Name	Tongrentangcare
Stock Code	02667
Company Full Name	Beijing Tong Ren Tang Healthcare Investment Co Ltd
Industry	Biotech & Pharma
Principal Activities	We are a subsidiary of Tongrentang that is strategically focused on traditional Chinese medicine medical services in China, providing comprehensive traditional Chinese medicine medical services to individual customers, standardized management services to institutional customers, and various health products and other products.
Listing Date	2026-07-07
Listing Rules Era	New Rules (after Aug 2025)
Listing Rules Chapter	To be extracted
Weighted Voting Rights (WVR)	No
Registered Address (Mainland China)	Headquarters and 5th Floor, Tower A, Yonggui Center, No. 47 Guangqumennei Principal Place Street, Dongcheng District, Beijing, PRC of Business in the PRC Principal Place of 40/F, Dah Sing Financial Ce
Business Address (Hong Kong)	香港灣仔皇后大道東248號大新金融中心40樓
Place of Incorporation	To be extracted
Listing Method	To be extracted
Listing Board	Main Board
Website	yiyang.tongrentang.com
Share Registrar	香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact	Computershare Hong Kong Investor Services Limited
A-Share/US Dual Listing	No

Offering Information

Offering Mechanism	Mechanism B
Offer Price	To be extracted
Offer Price Range	HK$ 5.48 - 6.21
Lot Size	500 shares
Entry Threshold	HK$ 4,150
Par Value	RMB 1.0 / shares
Offer Period	2026-06-26 to 2026-07-02
Global Offering Shares	108,153,500 shares
HK Public Offer Shares (Initial)	10,815,500 shares (10.0%)
Public Offer Lots (Initial)	21,631lots (10,815lots, 10,816lots)
International Placing Shares (Initial)	97,338,000 shares (90.0%)
Offer Ratio	~10.0%
Total Shares Post-IPO	465,362,049 shares
Greenshoe (Over-allotment Option)	No
Stabilizing Manager (Greenshoe)	—
Cornerstone Share	46.8%
Clawback Tiers	Mechanism B: no clawback mechanism
Reallocation Option	No
Total Global Offering Size	HK$ 671,633,235

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A

Lots Subscribed	Shares Subscribed	Subscription Amount (HKD)
1 lots	500	HK$ 3,105
2 lots	1,000	HK$ 6,210
3 lots	1,500	HK$ 9,315
4 lots	2,000	HK$ 12,420
5 lots	2,500	HK$ 15,525
6 lots	3,000	HK$ 18,630
7 lots	3,500	HK$ 21,735
8 lots	4,000	HK$ 24,840
9 lots	4,500	HK$ 27,945
10 lots	5,000	HK$ 31,050
12 lots	6,000	HK$ 37,260
14 lots	7,000	HK$ 43,470
16 lots	8,000	HK$ 49,680
18 lots	9,000	HK$ 55,890
20 lots	10,000	HK$ 62,100
30 lots	15,000	HK$ 93,150
40 lots	20,000	HK$ 124,200
50 lots	25,000	HK$ 155,250
60 lots	30,000	HK$ 186,300
70 lots	35,000	HK$ 217,350
80 lots	40,000	HK$ 248,400
90 lots	45,000	HK$ 279,450
100 lots	50,000	HK$ 310,500
120 lots	60,000	HK$ 372,600
140 lots	70,000	HK$ 434,700
160 lots	80,000	HK$ 496,800
180 lots	90,000	HK$ 558,900
200 lots	100,000	HK$ 621,000
400 lots	200,000	HK$ 1,242,000
600 lots	300,000	HK$ 1,863,000
800 lots	400,000	HK$ 2,484,000
1,000 lots	500,000	HK$ 3,105,000
1,200 lots	600,000	HK$ 3,726,000
1,400 lots	700,000	HK$ 4,347,000
1,600 lots	800,000	HK$ 4,968,000

Pool B

Lots Subscribed	Shares Subscribed	Subscription Amount (HKD)
1,800 lots	900,000	HK$ 5,589,000
2,000 lots	1,000,000	HK$ 6,210,000
4,000 lots	2,000,000	HK$ 12,420,000
6,000 lots	3,000,000	HK$ 18,630,000
10,815 lots	5,407,500	HK$ 33,580,575

Stock Connect Inclusion

HK Market Cap	HK$ 495.5M

26Q3 Fast Review
Inclusion Pathway	Quarterly Fast Inclusion
Est. Threshold	HK$ 19.28B Market cap gap 97%
Analysis Result	Market cap below threshold (gap 97%)

26Q4 Regular Review
Inclusion Pathway	Small Cap Regular Path
Est. Threshold	HK$ 9.56B Market cap gap 95%
Analysis Result	Market cap below threshold (gap 95%)

Valuation & Financials

Market Cap (at Offer Price)	HK$ 3,862,505,006
H-Share Market Cap (at Offer Price)	HK$ 1,196,243,031 - 1,355,596,574
Pre-IPO Valuation (Last Round)	Not disclosed
P/E Ratio	Not applicable (loss-making)
Profit/Loss Status	Net profit RMB 46.2 million
Period-End Cash Balance	RMB 287.7 million
Listing Expenses	~HK$ 69,700,000
Listing Expenses / Funds Raised	~11.0%
Total Pre-IPO Investment	To be extracted

First Day Performance

First Day Close	Loading...
First Day Open	HK$ --

Use of Proceeds

Use of Proceeds	1、約47.5%（或366.2百萬港元）將用于擴充公司的中醫醫療服務網絡； 2、約23.6%（或182.1百萬港元）預期將于2025年至2029年用于提升公司的中醫醫療服務能力； 3、約18.9%（或145.6百萬港元）預期將用于償還若干未償還銀行貸款； 4、約10.0%（或77.1百萬港元）將用作營運資金及其他一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)

China International Capital Corporation Hong Kong Securities Limited CE AEN894(sole)

Overall Coordinators (1)

China International Capital Corporation Hong Kong Securities Limited CE AEN894(sole)

Joint Global Coordinators (3)

China International Capital Corporation Hong Kong Securities Limited CE AEN894 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 广发证券（香港）经纪有限公司 CE AOB364

Joint Bookrunners (6)

China International Capital Corporation Hong Kong Securities Limited CE AEN894 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 广发证券（香港）经纪有限公司 CE AOB364 ABCI CAPITAL LIMITED CE AWL249 WEST BULL SECURITIES LIMITED CE BHT553 PATRONS SECURITIES LIMITED CE BPQ161

Joint Lead Managers (9)

China International Capital Corporation Hong Kong Securities Limited CE AEN894 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 广发证券（香港）经纪有限公司 CE AOB364 ABCI Securities Company Limited CE ACX411 WEST BULL SECURITIES LIMITED CE BHT553 PATRONS SECURITIES LIMITED CE BPQ161 Futu Securities International (Hong Kong) Limited CE AZT137 Livermore Holdings Limited CE BJN764 Tiger Brokers (HK) Global Limited CE BMU940

Service Providers

Role	Institution
Legal Advisor to Company	天元律师事务所（有限法律责任合伙） Tian Yuan Law Firm 通商律师事务所
Legal Advisor to Sponsors/Underwriters	海问律师事务所有限法律责任合伙汉坤律师事务所
Auditor and Reporting Accountant	Ernst & Young
Industry Advisor	Frost & Sullivan (Beijing) Inc., Shanghai Branch Co.
Compliance Advisor	Rainbow Capital (HK) Limited CE BPB716
Receiving Banks	Bank of China (Hong Kong) Limited 中国工商银行（亚洲）有限公司
H Share Registrar	香港中央证券登记有限公司

Cornerstone Investors

#	Investor Name	Investment Amount	Shares Subscribed	% of Offer Shares	% of Total Shares	Lock-up Period	Est. Unlock Date
1	航空港科技资本	219,000,000 HKD	37,435,500	34.61%	8.04%	7 months	2027-02-07
2	Aurora SF	49,600,000 HKD	8,471,500	7.83%	1.82%	7 months	2027-02-07
3	CICCFT（与场外掉期有关）	27,500,000 HKD	4,700,500	4.35%	1.01%	7 months	2027-02-07

Directors & Management

Chairman	Mr. Rao Zuhai
Company Secretary	喬雅楠

Executive Director (3)

#	Name	English Name	Type
1	饶祖海	—	Executive Director
2	鲁喦	—	Executive Director
3	桂嬗	—	Executive Director

Non-Executive Director (3)

#	Name	English Name	Type
1	朱峰	—	Non-Executive Director
2	孙恺	—	Non-Executive Director
3	邢茜	—	Non-Executive Director

Independent Non-Executive Director (3)

#	Name	English Name	Type
1	严志雄	—	Independent Non-Executive Director
2	张翔	—	Independent Non-Executive Director
3	高彦彬	—	Independent Non-Executive Director

Major Shareholders

Major Shareholders & Holdings	Tongrentang directly holds 83.98% of the unlisted shares and indirectly holds 9.85% of the unlisted shares through 同仁堂康養, 同仁堂傳承基金管理, 同仁堂醫療基金管理, 同仁堂養老基金, 同康基金 and 同清基金, in total controlling 93.83% of the voting rights.

Tongrentangcare 02667Prospectus Information